Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection

Colorectal cancer is a leading cause of cancer-related morbidity and mortality worldwide. Premalignant lesions that are flat and subtle in morphology are often missed in conventional colonoscopies. Patient-derived adenoma colonoids with high and low cMet expression and normal colonoids were implante...

Full description

Bibliographic Details
Main Authors: Xiaoli Wu, Chun-Wei Chen, Sangeeta Jaiswal, Tse-Shao Chang, Ruoliu Zhang, Michael K. Dame, Yuting Duan, Hui Jiang, Jason R. Spence, Sen-Yung Hsieh, Thomas D. Wang
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/19/4795
_version_ 1797576130348187648
author Xiaoli Wu
Chun-Wei Chen
Sangeeta Jaiswal
Tse-Shao Chang
Ruoliu Zhang
Michael K. Dame
Yuting Duan
Hui Jiang
Jason R. Spence
Sen-Yung Hsieh
Thomas D. Wang
author_facet Xiaoli Wu
Chun-Wei Chen
Sangeeta Jaiswal
Tse-Shao Chang
Ruoliu Zhang
Michael K. Dame
Yuting Duan
Hui Jiang
Jason R. Spence
Sen-Yung Hsieh
Thomas D. Wang
author_sort Xiaoli Wu
collection DOAJ
description Colorectal cancer is a leading cause of cancer-related morbidity and mortality worldwide. Premalignant lesions that are flat and subtle in morphology are often missed in conventional colonoscopies. Patient-derived adenoma colonoids with high and low cMet expression and normal colonoids were implanted orthotopically in the colon of immunocompromised mice to serve as a preclinical model system. A peptide specific for cMet was labeled with IRDye800, a near-infrared (NIR) fluorophore. This peptide was administered intravenously, and in vivo imaging was performed using a small animal fluorescence endoscope. Quantified intensities showed a peak target-to-background ratio at ~1 h after intravenous peptide injection, and the signal cleared by ~24 h. The peptide was stable in serum with a half-life of 3.6 h. Co-staining of adenoma and normal colonoids showed a high correlation between peptide and anti-cMet antibody. A human-specific cytokeratin stain verified the presence of human tissues implanted among surrounding normal mouse colonic mucosa. Peptide biodistribution was consistent with rapid renal clearance. No signs of acute toxicity were found on either animal necropsy or serum hematology and chemistries. Human colonoids provide a clinically relevant preclinical model to evaluate the specific uptake of a NIR peptide to detect premalignant colonic lesions in vivo.
first_indexed 2024-03-10T21:47:51Z
format Article
id doaj.art-a505608a8a824d53adc17fac7209fe7c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T21:47:51Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-a505608a8a824d53adc17fac7209fe7c2023-11-19T14:10:40ZengMDPI AGCancers2072-66942023-09-011519479510.3390/cancers15194795Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer DetectionXiaoli Wu0Chun-Wei Chen1Sangeeta Jaiswal2Tse-Shao Chang3Ruoliu Zhang4Michael K. Dame5Yuting Duan6Hui Jiang7Jason R. Spence8Sen-Yung Hsieh9Thomas D. Wang10Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USADepartment of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USADepartment of Mechanical Engineering, University of Michigan, Ann Arbor, MI 48109, USADepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USADivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USADepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USADepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USADivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USADepartment of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USAColorectal cancer is a leading cause of cancer-related morbidity and mortality worldwide. Premalignant lesions that are flat and subtle in morphology are often missed in conventional colonoscopies. Patient-derived adenoma colonoids with high and low cMet expression and normal colonoids were implanted orthotopically in the colon of immunocompromised mice to serve as a preclinical model system. A peptide specific for cMet was labeled with IRDye800, a near-infrared (NIR) fluorophore. This peptide was administered intravenously, and in vivo imaging was performed using a small animal fluorescence endoscope. Quantified intensities showed a peak target-to-background ratio at ~1 h after intravenous peptide injection, and the signal cleared by ~24 h. The peptide was stable in serum with a half-life of 3.6 h. Co-staining of adenoma and normal colonoids showed a high correlation between peptide and anti-cMet antibody. A human-specific cytokeratin stain verified the presence of human tissues implanted among surrounding normal mouse colonic mucosa. Peptide biodistribution was consistent with rapid renal clearance. No signs of acute toxicity were found on either animal necropsy or serum hematology and chemistries. Human colonoids provide a clinically relevant preclinical model to evaluate the specific uptake of a NIR peptide to detect premalignant colonic lesions in vivo.https://www.mdpi.com/2072-6694/15/19/4795imagingcancerearly detectioncMetpeptidefluorescence
spellingShingle Xiaoli Wu
Chun-Wei Chen
Sangeeta Jaiswal
Tse-Shao Chang
Ruoliu Zhang
Michael K. Dame
Yuting Duan
Hui Jiang
Jason R. Spence
Sen-Yung Hsieh
Thomas D. Wang
Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
Cancers
imaging
cancer
early detection
cMet
peptide
fluorescence
title Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
title_full Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
title_fullStr Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
title_full_unstemmed Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
title_short Near-Infrared Imaging of Colonic Adenomas In Vivo Using Orthotopic Human Organoids for Early Cancer Detection
title_sort near infrared imaging of colonic adenomas in vivo using orthotopic human organoids for early cancer detection
topic imaging
cancer
early detection
cMet
peptide
fluorescence
url https://www.mdpi.com/2072-6694/15/19/4795
work_keys_str_mv AT xiaoliwu nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT chunweichen nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT sangeetajaiswal nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT tseshaochang nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT ruoliuzhang nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT michaelkdame nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT yutingduan nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT huijiang nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT jasonrspence nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT senyunghsieh nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection
AT thomasdwang nearinfraredimagingofcolonicadenomasinvivousingorthotopichumanorganoidsforearlycancerdetection